首页 | 本学科首页   官方微博 | 高级检索  
     

IgH基因单克隆重排检测及其在B细胞性非霍奇金淋巴瘤诊断中的应用
引用本文:李银珍,王芳,邵琼,张旭,邓玲,汤涛,张晓,吴秋良. IgH基因单克隆重排检测及其在B细胞性非霍奇金淋巴瘤诊断中的应用[J]. 中国病理生理杂志, 2012, 28(11): 1994-1998. DOI: 10.3969/j.issn.1000-4718.2012.11.016
作者姓名:李银珍  王芳  邵琼  张旭  邓玲  汤涛  张晓  吴秋良
作者单位:华南肿瘤学国家重点实验室,中山大学肿瘤防治中心 分子诊断科,病理科,广东 广州 510060
基金项目:中山大学肿瘤防治中心单病种科研基金
摘    要: 目的:建立准确可靠、操作性强、适用于临床实际工作的免疫球蛋白重链(immunoglobulin heavy chain,IgH)基因单克隆重排检测方法,用于B细胞性非霍奇金淋巴瘤(B-cell non-Hodgkin lymphoma,B-NHL)的辅助诊断。方法:采用骨架区(framework region,FR)引物FR2、FR3和重链连接区 (joining region of heavy chain,JH)引物LJH、VLJH组合、A管+B管模式、半巢式聚合酶链式反应(polymerase chain reaction,PCR)法对121例B-NHL、58例T细胞性非霍奇金淋巴瘤(T-cell non-Hodgkin lymphoma,T-NHL)和19例淋巴结反应性增生的石蜡组织进行IgH基因单克隆重排检测,分析IgH基因单克隆重排检出率在B-NHL组、T-NHL组和淋巴结反应性增生组中的差异,以及B-NHL中联合应用FR2和FR3与单独应用FR2、FR3之间IgH基因单克隆重排检出率的差异。结果:118例成功检测的B-NHL中,IgH基因单克隆重排检出率为81%(96/118);54例成功检测的T-NHL中,IgH基因单克隆重排检出率为4%(2/54);19例成功检测的淋巴结反应性增生中未检出IgH基因单克隆重排。B-NHL组与T-NHL组、淋巴结反应性增生组相比,IgH基因单克隆重排检出率差异具有显著性(P<0.05)。B-NHL中, FR2基因单克隆重排检出率为58%(68/118),FR3基因单克隆重排检出率为55%(65/118),联合应用FR2和FR3,IgH基因单克隆重排检出率为81%(96/118),联合应用FR2和FR3与单独应用FR2、FR3的检出率有显著差异(P<0.05)。结论:采用FR2、FR3、LJH及VLJH引物组合、A管+B管模式和半巢式PCR法进行石蜡组织IgH基因单克隆重排检测,简单易行,结果准确可靠,阳性率较高,可用于临床B-NHL的辅助诊断。

关 键 词:淋巴瘤  免疫球蛋白  基因重排  
收稿时间:2012-05-18

Detection of monoclonal immunoglobulin heavy chain gene rearrangements and its application in diagnosis of B-cell non-Hodgkin lymphoma
LI Yin-zhen,WANG Fang,SHAO Qiong,ZHANG Xu,DENG Ling,TANG Tao,ZHANG Xiao,WU Qiu-liang. Detection of monoclonal immunoglobulin heavy chain gene rearrangements and its application in diagnosis of B-cell non-Hodgkin lymphoma[J]. Chinese Journal of Pathophysiology, 2012, 28(11): 1994-1998. DOI: 10.3969/j.issn.1000-4718.2012.11.016
Authors:LI Yin-zhen  WANG Fang  SHAO Qiong  ZHANG Xu  DENG Ling  TANG Tao  ZHANG Xiao  WU Qiu-liang
Affiliation:Department of Molecular Diagnosis, Department of Pathology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Abstract:AIM: To establish a reliable and feasible protocol for detection of monoclonal immunoglobulin heavy chain (IgH) gene rearrangements for routine diagnosis of B-cell non-Hodgkin lymphoma (B-NHL). METHODS: Using the primer combinations of FR2, FR3, LJH and VLJH, mode tube A+ tube B, and semi-nested PCR, the monoclonal IgH gene rearrangements in 121 cases of B-NHL, 58 cases of T-cell non-Hodgkin lymphoma (T-NHL) and 19 cases of reactive lymphoid hyperplasia were detected. The differences of clonality detection rate between B-NHL group and T-NHL group, B-NHL group and reactive lymphoid hyperplasia group, and between the use of FR2, FR3 and FR2+FR3 primers were analyzed. RESULTS:  The clonality detection rates of B-NHL, T-NHL and reactive lymphoid hyperplasia were 81% (96/118), 4% (2/54) and 0% (0/19). There were remarkable differences between B-NHL group and T-NHL group, B-NHL group and reactive lymphoid hyperplasia group in monoclonal IgH gene rearrangements (P<0.05). In B-NHL group, monoclonality was found in 58% of the cases using primer FR2, 55% using FR3, and 81% using the combination of both primers, with significant differences (P<0.05). CONCLUSION: Using the primer combinations of FR2, FR3, LJH and VLJH, detection of paraffin-embedded tissues, the method of tube A+tube B mode and semi-nested PCR for determining monoclonal IgH gene rearrangements is feasible and reliable, and the clonality detection rate is high enough for clinical diagnosis of B-NHL.
Keywords:Lymphoma  Immunoglobulin  Gene rearrangement
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号